Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.57
Delayed Data
As of Jul 20
 -0.05 / -0.89%
Today’s Change
2.87
Today|||52-Week Range
9.25
-12.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues17.3M13.6M48.3M26.4M
 
 
 
 
 
Cost of Goods Sold98.0K33.5K1.7M2.2M
 
 
 
 
 
Depreciation And Amortization304.0K177.0K180.0K483.0K
 
 
 
 
 
 
Operating ExpensesGross Income16.9M13.4M46.4M23.7M
 
 
 
 
 
General Expenses42.6M59.2M85.8M72.3M
 
 
 
 
 
Research And Development37.7M51.8M72.8M61.0M
 
 
 
 
 
Total Operating Expenses43.0M59.4M87.7M75.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.7M-45.8M-39.4M-48.6M
 
 
 
 
 
Extraordinary Credit5.3M5.5M0.000.00
 
 
 
Extraordinary Charge-5.0M0.00-564.0K-843.0K
 
 
 
 
Interest Expense On Debt4.8M5.0M5.2M6.5M
 
 
 
 
 
Other Expenses0.000.001.7M11.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-30.1M-45.2M-43.0M-55.1M
 
 
 
 
 
Net Income-30.1M-45.2M-43.0M-55.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS55.2M66.8M72.9M73.7M
 
 
 
 
 
Shares To Calculate EPS Diluted55.2M66.8M72.9M73.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.55-$0.68-$0.59-$0.75
 
 
 
 
 
EPS Diluted-$0.55-$0.68-$0.59-$0.75